Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dermatology expert Dr. Hannah Pederson answers why people experience acne breakouts even when following what seems like a healthy skincare routine.
-
White Oak, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced it is sharing information about the agency’s flexible approach to overseeing chemistry,...
-
Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone...
-
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva’s anti-IL-15 candidate,...
-
Day One today announced the release of preliminary 2025 OJEMDA™ net product revenue and provides 2026 net product revenue guidance
-
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million to support Teva’s anti-IL-15 candidate...
-
Phase 1/2a study with lead Radio-DARPin MP0712 initiated; first patient dosing expected Q1 2026, initial data anticipated in 2026Full imaging and dosimetry data from MP0712 compassionate care program...
-
MIAMI, FL, Jan. 10, 2026 (GLOBE NEWSWIRE) -- Why Consumers Are Researching Ozempatch Ingredients in 2026 OzemPatches, also promoted under the name Rejuvacare Ozempatch, is a topical herbal...
-
RALEIGH, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- La estrategia de crecimiento de Attindas Hygiene Partners dio hoy un importante paso hacia adelante con la adquisición de Societá Italiana...
-
北卡羅來納州羅利, Jan. 10, 2026 (GLOBE NEWSWIRE) -- Attindas Hygiene Partners 今天收購 Società Italiana Lavorazione Cellulosa (SILC S.p.A.)，標誌其增長策略邁出重要一步。Attindas 已與 SILC 簽立股份購買協議，將這間 53 年歷史的家族企業收歸旗下。 SILC...